Analysts See $-0.05 EPS for Biomerica, Inc. (BMRA); Donegal Mutual Insurance Co (DGICB) Sentiment Is 1

March 14, 2018 - By Clifton Ray

Donegal Group Inc., an insurance holding company, provides property and casualty insurance to businesses and individuals in the Mid-Atlantic, Midwestern, New England, and southern states. The company has market cap of $414.37 million. It operates through four divisions: Investment Function, Personal Lines of Insurance, Commercial Lines of Insurance, and Investment in DFSC. It has a 56.15 P/E ratio. The firm offers private passenger automobile policies that provide protection against liability for bodily injury and property damage arising from automobile accidents, as well as protection against loss from damage to automobiles.

Analysts expect Biomerica, Inc. (NASDAQ:BMRA) to report $-0.05 EPS on April, 13.They anticipate $0.01 EPS change or 25.00% from last quarter’s $-0.04 EPS. After having $-0.03 EPS previously, Biomerica, Inc.’s analysts see 66.67% EPS growth. The stock increased 0.23% or $0.01 during the last trading session, reaching $4.32. About 10,657 shares traded. Biomerica, Inc. (NASDAQ:BMRA) has risen 66.46% since March 14, 2017 and is uptrending. It has outperformed by 49.76% the S&P500.

Biomerica, Inc., together with its subsidiaries, develops, makes, and markets medical diagnostic products for the early detection and monitoring of chronic diseases and medical conditions worldwide. The company has market cap of $36.90 million. The companyÂ’s diagnostic test kits are used to analyze blood, urine, or fecal samples from patients in the diagnosis of various diseases and other medical complications; and to measure the level of specific hormones, antibodies, antigens, or other substances, which exist in the human body in extremely small concentrations. It currently has negative earnings. It primarily focuses on products for gastrointestinal, food intolerances, diabetes, and esoteric tests.

Investors sentiment increased to 1 in Q3 2017. Its up 0.75, from 0.25 in 2017Q2. It improved, as 2 investors sold Biomerica, Inc. shares while 2 reduced holdings. 1 funds opened positions while 0 raised stakes. 66,682 shares or 11.38% less from 75,249 shares in 2017Q2 were reported. North Star Inv Corp accumulated 250 shares or 0% of the stock. Wells Fargo Mn has 0% invested in Biomerica, Inc. (NASDAQ:BMRA) for 6,500 shares. Bankshares Of America De accumulated 3,832 shares or 0% of the stock. 10,077 were reported by Panagora Asset. Millennium Mngmt Lc invested 0% of its portfolio in Biomerica, Inc. (NASDAQ:BMRA). Malaga Cove Lc has invested 0.03% in Biomerica, Inc. (NASDAQ:BMRA).

Since January 23, 2018, it had 4 buys, and 0 insider sales for $65,333 activity. On Friday, February 2 Irani Zackary S. bought $3,960 worth of Biomerica, Inc. (NASDAQ:BMRA) or 1,000 shares. Shares for $49,324 were bought by CANO FRANCIS.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: